Hybrid MR: Risks, Roles, Rewards, Results
Member-Initiated Symposium
Wednesday, 19 May 2021
Concurrent 7 |
12:00 - 12:30 |
Moderators: Glenn Cahoon & Kylie Walters |
Session Number: MIS-21
Parent Session: Hybrid MR: Risks, Roles, Rewards, Results
Session Number:MIS-21
Organizers
Claire Mulcahy, Rhys Slough, Thao Tran
Overview
Hybrid MR modalities involve a range of rapidly evolving technologies. Such technologies are starting to be implemented more widely in the clinical setting. However, the challenges and advantages of such techniques are relatively poorly understood compared to more clinically established MR methods. This symposium will provide a forum for clinicians, surgeons, MR technologists/radiographers, Ph.D.s/MR scientists and others to engage in discussions as to how hybrid MR suites can benefit patient care and what the challenges and opportunities are for the various practitioners. The emergence of combining MR technology with operating environments, PET and radiotherapy bring exciting benefits to patients but also challenges from a typical MR viewpoint.
The symposium will consist of four 25-minute presentations and a 20-minute panel discussion. Clinicians, surgeons, MR technologists/radiographers, and Ph.D.s/MR scientists will discuss whether these systems offer value for resources, workforce considerations, and patient benefits. The panel discussion will foster dialogue among MRI professionals and explore the considerations required when there are additional stakeholders or components beyond the traditional MR environment.
Target Audience
Clinicians, MR technologists/radiographers, MR scientists/Ph.D.s, and MR vendors.
Educational Objectives
As a result of attending this course, participants should be able to:
Upon completion of this course, participants should be able to:
- Review the concepts of hybrid MR technology;
- List safety considerations of hybrid MR technology with non-MR risks;
- Define workforce considerations, non-MR technologist/radiographer use and training; and
- Discuss the financial value and productivity of hybrid MR technology.
|
|
|
PET-MR Segment
Marius Mayerhoefer
Memorial Sloan Kettering Cancer Center
|
|
|
|
Intra-Operative MR Segment
Jeffrey Weinberg
The University of Texas MD Anderson Cancer Center
|
|
|
|
MR-Linac Segment
Gary Liney
Ingham Institute for Applied Medical Research
|
|
|
|
Hybrid PET Modalities in Precision Oncology
Pek-Lan Khong
The University of Hong Kong
|